Skip to content
777 Sourcing.

Capability

development and commercialization of critical care products

Suppliers
1
States & provinces
1
Countries
1

1 development and commercialization of critical care products supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CITIUS PHARMACEUTICALS, INC.

CRANFORD, NJ

Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products. LYMPHIR (denileukin diftitox-cxdl), a targeted immune therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL), is approved by the FDA.

clinical trialsdrug developmentmanufacturingstem cell therapy

Compiled from public sources

Related capabilities

Other processes offered by the shops that list development and commercialization of critical care products.

Browse all capabilities